Ruilope L M, Campo C, Rodicio J L
Curr Opin Nephrol Hypertens. 1998 Mar;7(2):145-8. doi: 10.1097/00041552-199803000-00001.
The presence of proteinuria has been shown to be an excellent predictor for a worse outcome of renal function. Both proteinuria and arterial hypertension often coexist in the same patient, and therapy must be directed at decreasing protein excretion in the urine as well as lowering the blood pressure. Any antihypertensive agent has the capacity to lower proteinuria simply by lowering blood pressure. Furthermore, the antiproteinuric capacity of angiotensin-converting enzyme inhibitors can be equalized by other agents or their combination, provided that the fall in blood pressure is great enough. For this reason studies are needed in which the strict control of arterial hypertension combined with a decrease in proteinuria are considered.
蛋白尿的出现已被证明是肾功能预后较差的一个极佳预测指标。蛋白尿和动脉高血压常常在同一患者中并存,治疗必须针对减少尿蛋白排泄以及降低血压。任何抗高血压药物都有通过降低血压来降低蛋白尿的能力。此外,只要血压下降幅度足够大,血管紧张素转换酶抑制剂的抗蛋白尿能力可被其他药物或其联合用药所抵消。因此,需要开展相关研究,将严格控制动脉高血压与减少蛋白尿结合起来考虑。